This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.Need a new registration confirmation email? Click here

Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system disorders.View VNDA key stats

Vanda Pharmaceuticals Inc - VNDA - EQUITY

Reviewed By: TheStreet Ratings on July 30, 2015.

Report Summary: TheStreet Ratings team rates Vanda Pharmaceuticals Inc as a
Hold with a ratings score of C.

Report Snippet: We rate VANDA PHARMACEUTICALS INC (VNDA) a HOLD. The primary factors that have impacted our rating are mixed - some indicating strength, some showing weaknesses, with little evidence to justify the expectation of either a positive or negative performance for this stock relative to most other stocks. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and notable return on equity. However, as a counter to these strengths, we find that the stock has had a generally disappointing performance in the past year.